Finance

Lists
Outlook: 32.3% bullish·9.7% bearish
Go to analysis
CVS:NYSE
CVS Health Corp
86,16 US$
-1,87%
(-1,64) 1D
86,44 US$
+0,32% (+0,28)
After hours
Closed: 9 ოქტ, 16:00:09 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVS...
Open
85,90 US$
High
88,86 US$
Low
85,80 US$
Mkt. cap
110,20 მლრ.
Avg. vol.
7,87 მლნ.
Volume
11,65 მლნ.
Dividend
3,09%
Quarterly dividend
0,67 US$
Ex-dividend date
23 აპრ. 2026
P/E ratio
22,84
52-wk high
110,68 US$
52-wk low
69,51 US$
EPS
3,77 US$
Beta
0,60
Shares outstanding
1,28 მლრდ.
No. of employees
260 ათ.
Open
85,90 US$
High
88,86 US$
Low
85,80 US$
Mkt. cap
110,20 მლრ.
Avg. vol.
7,87 მლნ.
Volume
11,65 მლნ.
Dividend
3,09%
Quarterly dividend
0,67 US$
Ex-dividend date
23 აპრ. 2026
P/E ratio
22,84
52-wk high
110,68 US$
52-wk low
69,51 US$
EPS
3,77 US$
Beta
0,60
Shares outstanding
1,28 მლრდ.
No. of employees
260 ათ.
News stories
From web sources and news partners
Yahoo Finance Singapore
Yahoo Finance Singapore
·
9 საათის წინ
CVS Health (CVS) Opens New Pharmacy Sites As Undervalued Narrative Holds
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. Wikipedia
About CVS Health Corp
CEOდავიდ ჯოინერ
Employees260 ათ.
Founded1963
HeadquartersWoonsocket, როდ-აილენდი, ამერიკის შეერთებული შტატები
SectorHealth care provider
Analyst ratings
Based on 17 analysts giving stock ratings to CVS in the past 3 months
Strong buy
Buy
17
Hold
0
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for CVS in the last 3 months.
Highest
Current 86,16 US$
125,00 US$ (+45,08%)
Average
115,06 US$ (+33,54%)
Lowest
107,00 US$ (+24,19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Rhyee
TD Cowen
Buy
Maintained
110,00 US$
+27,7%
10/09/2026
Ben Hendrix
RBC Capital
Buy
Maintained
113,00 US$
+31,2%
10/07/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
110,00 US$
+27,7%
10/06/2026
Lance Wilkes
Bernstein
Buy
Maintained
112,00 US$
+30%
10/05/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
125,00 US$
+45,1%
10/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
123,00 US$
+42,8%
09/15/2026
Kevin Caliendo
UBS
Buy
Reiterated
118,00 US$
+37%
09/03/2026
Brian Tanquilut
Jefferies
Buy
Maintained
120,00 US$
+39,3%
08/31/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
113,00 US$
+31,2%
08/26/2026
Steven Silver
Argus Research
Buy
Maintained
114,00 US$
+32,3%
08/18/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
118,00 US$
+37%
08/12/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
111,00 US$
+28,8%
08/10/2026
Michael Ha
Robert W. Baird
Buy
Maintained
107,00 US$
+24,2%
08/06/2026
David S Macdonald
Truist Financial
Buy
Reiterated
118,00 US$
+37%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
108,00 US$
+25,3%
08/06/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
116,00 US$
+34,6%
07/27/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
120,00 US$
+39,3%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
110,00 US$
+27,7%
07/07/2026
Rajesh Kumar
HSBC
Hold
Maintained
103,00 US$
+19,5%
07/06/2026
George Hill
Deutsche Bank
Buy
Maintained
92,00 US$
+6,8%
05/07/2026
Courtney Breen
Bernstein
Buy
Maintained
94,00 US$
+9,1%
03/30/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
98,00 US$
+13,7%
03/24/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
-
-
02/11/2026
Last report
5 აგვ. 2026
Fiscal period
Q2 2026
2,58 US$ / 1,85 US$
+39,36%beat
Revenue / Est. (USD)
105,46 მლრ. / 100,09 მლრ.
+5,36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
102,24 მლრ.
105,10 მლრ.
99,85 მლრდ.
105,46 მლრ.
Cost of goods sold
89,06 მლრდ.
92,13 მლრდ.
84,80 მლრდ.
90,35 მლრდ.
Cost of revenue
89,06 მლრდ.
92,13 მლრდ.
84,80 მლრდ.
90,35 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,86 მლრდ.
11,32 მლრდ.
10,93 მლრდ.
11,04 მლრდ.
Operating expense
10,86 მლრდ.
11,32 მლრდ.
10,93 მლრდ.
11,04 მლრდ.
Total operating expenses
99,92 მლრდ.
103,45 მლრ.
95,73 მლრდ.
101,38 მლრ.
Operating income
2,32 მლრდ.
1,65 მლრდ.
4,12 მლრდ.
4,07 მლრდ.
Other non operating income
26,00 მლნ.
-88,00 მლნ.
32,00 მლნ.
31,00 მლნ.
EBT including unusual items
-3,48 მლრდ.
1,35 მლრდ.
3,94 მლრდ.
3,98 მლრდ.
EBT excluding unusual items
2,19 მლრდ.
1,37 მლრდ.
3,95 მლრდ.
3,99 მლრდ.
Income tax expense
508,00 მლნ.
-1,57 მლრდ.
981,00 მლნ.
982,00 მლნ.
Effective tax rate
-14,59%
-115,88%
24,91%
24,69%
Other operating expenses
-
-
-
-
Net income
-3,98 მლრდ.
2,94 მლრდ.
2,94 მლრდ.
2,98 მლრდ.
Net profit margin
-3,89%
2,80%
2,95%
2,82%
Earnings per share
1,60
1,09
2,57
2,58
Interest and investment income
632,00 მლნ.
594,00 მლნ.
574,00 მლნ.
641,00 მლნ.
Interest expense
-784,00 მლნ.
-787,00 მლნ.
-774,00 მლნ.
-757,00 მლნ.
Net interest expenses
-152,00 მლნ.
-193,00 მლნ.
-200,00 მლნ.
-116,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
3,45 მლრდ.
2,80 მლრდ.
5,23 მლრდ.
5,20 მლრდ.
Gain or loss from assets sale
-483,00 მლნ.
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები